![Karin Heidemann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Karin Abarca Heidemann formerly worked at Rockland Immunochemicals, Inc., as Vice President-Scientific Operations from 2017 to 2019 and Champions Oncology, Inc., as Executive VP-Global Scientific Operations from 2021 to 2025.
Dr. Heidemann received her undergraduate degree from Universität zu Köln.
Antiguos cargos conocidos de Karin Heidemann.
| Empresas | Cargo | Fin |
|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Director Técnico/Científico/I+D | 01/08/2025 |
Rockland Immunochemicals, Inc.
 Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures antibodies and related reagents | Corporate Officer/Principal | 01/09/2019 |
Formación de Karin Heidemann.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
1
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Champions Oncology, Inc.
 Champions Oncology, Inc. BiotechnologyHealth Technology Provides advanced technology solutions and services for oncology drugs | Health Technology |
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures antibodies and related reagents | Health Technology |
- Bolsa de valores
- Insiders
- Karin Heidemann
